Cyclooxygenase-2 expression in animal cancers (Q37793667)

23 August 2017

Cyclooxygenase-2 expression in animal cancers (English)

1 reference

23 August 2017

M Doré

1

1 reference

23 August 2017

27 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

48

1 reference

23 August 2017

1

1 reference

23 August 2017

254-265

1 reference

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer

23 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Review paper: Cancer chemopreventive compounds and canine cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-2 expression in malignant melanoma: a novel prognostic marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002-2007)*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Immunohistochemical expression of cyclooxygenase-2 in canine ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Estrogen-dependent induction of cyclooxygenase-2 in the canine prostate in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression of cyclooxygenase-1 and -2 in naturally occurring squamous cell carcinomas in horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression of COX-2 in stomach carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Targeting prostaglandin E EP receptors to inhibit metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-1 and COX-2 expression in feline oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

In vitro cyclooxygenase-2 protein expression and enzymatic activity in neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression of cyclooxygenase-2 in canine epithelial nasal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Chemoprevention of mammary carcinogenesis in female rats by rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Regulation of COX-2 expression in canine prostate carcinoma: increased COX-2 expression is not related to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Immunohistochemical evaluation of cyclooxygenase expression in corneal squamous cell carcinoma in horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 expression correlates with diminished survival in invasive breast cancer treated with mastectomy and radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression and regulation of cyclooxygenase-2 in normal and neoplastic canine keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

The anti-proliferative potency of celecoxib is not a class effect of coxibs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenases: structural, cellular, and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression of cyclooxygenase-2 by equine ocular and adnexal squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Prostanoid receptor EP1 expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Aspirin use and reduced risk of gastrointestinal tract cancers in the American Cancer Society prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Prostaglandins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-2 inhibitors in cancer treatment and prevention, a recent development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

COX-2 Expression in Canine Normal and Neoplastic Mammary Gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300985810379434

21 January 2018

Identifiers

DOI

10.1177/0300985810379434

1 reference

23 August 2017

1 reference

PubMed ID

20876365